U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 350 points on Friday.The Dow traded down 0.45% to 48,487.12 while the NASDAQ fell 1.60% to 23,216.22. The S&P 500 also fell, dropping, 1.04% to 6,829.12.Check This Out: Jim Cramer Rejects MicroStrategy: ‘I Just Want Bitcoin’Leading and Lagging SectorsConsumer staples shares jumped by 0.3% on Friday.In trading on Friday, information technology stocks fell by 2.5%.Top HeadlineBroadcom Inc. (NASDAQ:AVGO) reported bette ...

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 350 points on Friday.The Dow traded down 0.45% to 48,487.12 while the NASDAQ fell 1.60% to 23,216.22. The S&P 500 also fell, dropping, 1.04% to 6,829.12.Check This Out: Jim Cramer Rejects MicroStrategy: ‘I Just Want Bitcoin’Leading and Lagging SectorsConsumer staples shares jumped by 0.3% on Friday.In trading on Friday, information technology stocks fell by 2.5%.Top HeadlineBroadcom Inc. (NASDAQ:AVGO) reported bette ...

Company Performance - Lululemon Athletica Inc. reported quarterly earnings of $2.59 per share, exceeding the analyst estimate of $2.27 by 14.15% [2] - The company's quarterly revenue reached $2.57 billion, surpassing the Street estimate of $2.48 billion and increasing from $2.4 billion in the same period last year [2] Market Movements - cbdMD Inc. shares surged 101% to $1.26 after regaining full compliance with NYSE American listing standards [9] - Akanda Corp shares rose 42% to $1.12 following a report on potential reclassification of marijuana as a Schedule III drug [9] - Zedge Inc. shares increased by 33% to $3.24 after reporting better-than-expected quarterly financial results [9] - Applied Therapeutics Inc. shares fell 48% to $0.11 after Cycle Pharmaceuticals announced plans to acquire the company [9] - Fermi Inc. shares dropped 40% to $9.19 after First Tenant notified the company of AICA termination [9] - Tenaya Therapeutics Inc. shares decreased by 29% to $0.97 after announcing a $60 million public offering priced at $1.20 per unit [9]

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Friday.Following the market opening Friday, the Dow traded up 0.24% to 48,819.22 while the NASDAQ fell 0.34% to 23,514.76. The S&P 500 also fell, dropping, 0.13% to 6,892.15.Check This Out: Jim Cramer Rejects MicroStrategy: ‘I Just Want Bitcoin’Leading and Lagging SectorsMaterials shares jumped by 0.9% on Friday.In trading on Friday, information technology stocks fell by 0.9%.Top HeadlineLululemon Athletica Inc. ...

Core Insights - Lululemon Athletica Inc reported better-than-expected third-quarter results, with earnings of $2.59 per share, surpassing analyst estimates of $2.27 by 14.15% [1] - The company's quarterly revenue reached $2.57 billion, exceeding the Street estimate of $2.48 billion and showing an increase from $2.4 billion in the same period last year [1] - Following the positive earnings report, Lululemon raised its full-year guidance and announced a CEO succession plan along with an increase in its share buyback program [2] Stock Performance - Lululemon shares rose 9% to $203.82 in pre-market trading after the earnings announcement [2] - Other notable stock movements included cbdMD, Inc. gaining 57.6% and Paranovus Entertainment Technology Ltd. surging 52.2% in pre-market trading [5]

Core Insights - Several small-cap biotech and therapeutics companies experienced significant gains in after-hours trading, driven by earnings updates, financial guidance, and regulatory developments [1] Company Summaries - Inotiv, Inc. (NOTV) saw a 36.61% increase in after-hours trading to $0.94, recovering from a 33.20% decline at the close, following preliminary Q4 revenue expectations of $137.5 million to $138.5 million and full-year revenue projections of $512.5 million to $513.5 million [2] - Applied Therapeutics, Inc. (APLT) rose 16.89% to $0.33 after a 30.19% gain at the close, with investors reacting positively to a narrower Q3 net loss of $19.0 million, or $0.13 per share, compared to a $68.6 million loss, or $0.48 per share, in the same quarter last year [3] - Alumis Inc. (ALMS) advanced 7.09% to $5.97, despite reporting a Q3 net loss of $110.8 million, wider than the $93.1 million loss in the prior year, with $2.1 million in collaboration income potentially boosting investor confidence [4] - TELA Bio, Inc. (TELA) increased 7.89% to $1.23 after a 14.08% gain at the close, reporting a reduced Q3 net loss of $8.6 million compared to $10.4 million a year earlier, with revenue growth of 9% to $20.7 million and revised 2025 guidance projecting at least 16% revenue growth over 2024 [5] - Corcept Therapeutics Inc. (CORT) gained 4.90% to $78.80, reflecting continued investor interest despite no specific news released [6] - BioRestorative Therapies, Inc. (BRTX) jumped 8.06% to $1.34, rebounding from a 6.77% decline at the close, following the announcement of a Type B meeting with the FDA to discuss a potential accelerated Biologics License Application pathway for its BRTX-100 program [7]

Group 1: Applied Therapeutics, Inc. (APLT) - The stock price of Applied Therapeutics rose to $0.35 due to developments in products targeting cardiovascular disease and diabetic complications [1] - The company faces uncertainties regarding FDA approval for its lead drug, which may lead to a decline in stock price [1] - Trading volume surged to over 20 million, significantly higher than the average of 4.88 million [1][5] Group 2: Alpha Technology Group Limited (ATGL) - Alpha Technology Group's stock price increased to $16.98, driven by its focus on cloud-based IT services and AI-powered solutions [2] - A strategic partnership with AB DAO aims to enhance AI and blockchain technology in supply chain management and IoT, boosting investor confidence [2] Group 3: WeShop Holdings Limited (WSHP) - WeShop's stock price rose to $48 following its debut on the Nasdaq Capital Market [3] - The company integrates social interactions with shopping, enhancing product discovery and retailer growth [3] - WeShop plans to launch its app in the U.S., partnering with retailers and offering users ownership in the company [3] Group 4: Market Trends - The movements in stock prices reflect diverse sectors, with companies under close scrutiny by investors and analysts for growth opportunities and market impacts [4][5]

Core Insights - The after-hours trading session on November 14, 2025, saw significant movements in biotech and therapeutics stocks due to various corporate updates and financial results [1] Company Summaries - Repare Therapeutics Inc. (RPTX) experienced a 30.32% increase, closing at $2.15, following the announcement of a definitive agreement for acquisition by XenoTherapeutics, with shareholders set to receive $1.82 per share plus a contingent value right. The company reported cash and cash equivalents of $112.6 million as of September 30, 2025, up from $109.5 million at the end of June [2] - Senti Biosciences, Inc. (SNTI) rose 7.45% to $1.73 after reporting a net loss of $18.1 million, or $0.69 per share, for Q3 2025. Cash and cash equivalents decreased to $12.2 million from $48.3 million at year-end 2024 [3] - Applied Therapeutics, Inc. (APLT) advanced 8.15% to $0.24, reporting a net loss of $19.0 million, or $0.13 per share, for Q3 2025, an improvement from a net loss of $68.6 million, or $0.48 per share, in the same period of 2024. Cash and cash equivalents totaled $11.9 million, down from $79.4 million at the end of 2024 [4] - RenovoRx, Inc. (RNXT) climbed 6.28% to $0.80, reporting revenues of approximately $266,000 for Q3 2025, with a net loss of $2.9 million compared to $2.5 million in the same period of 2024 [5] - Nuvalent, Inc. (NUVL) gained 9.33%, closing at $105.50, and announced plans for a webcast to discuss pivotal data for its investigational ALK-selective inhibitor in patients with advanced ALK-positive non-small cell lung cancer [6]

Company Performance - JD.com reported a quarterly revenue growth of 14.9% year-over-year to $42.01 billion, surpassing the analyst consensus estimate of $41.33 billion [2] - JD posted an adjusted net income per ADS of 52 cents, exceeding the analyst consensus estimate of 34 cents [2] Stock Movements - Mersana Therapeutics Inc shares surged 205% to $27.06 after announcing its acquisition by Day One Biopharmaceuticals [8] - Nuvve Holding Corp shares increased 215% to $0.4916 following an aggregation agreement in Japan [8] - Ondas Holdings Inc shares rose 24% to $6.82 after reporting better-than-expected third-quarter results and raising its FY25 sales guidance [8] - Korro Bio Inc shares dropped 79% to $6.48 after announcing a wind-down of research and development activities [8] - Applied Therapeutics Inc shares fell 44% to $0.5070 following third-quarter results [8] - EPWK Holdings Ltd shares decreased 33% to $0.0434 after announcing a 40-for-1 share consolidation effective November 17 [8]

Company Performance - JD.com reported a quarterly revenue growth of 14.9% year-over-year to $42.01 billion, surpassing the analyst consensus estimate of $41.33 billion [2] - JD posted an adjusted net income per ADS of 52 cents, exceeding the analyst consensus estimate of 34 cents [2] Stock Movements - Mersana Therapeutics Inc shares surged 205% to $27.06 after announcing its acquisition by Day One Biopharmaceuticals [8] - Nuvve Holding Corp shares increased 215% to $0.4916 following an aggregation agreement in Japan [8] - Ondas Holdings Inc shares rose 24% to $6.82 after reporting better-than-expected third-quarter results and raising its FY25 sales guidance [8] - Korro Bio Inc shares dropped 79% to $6.48 after announcing a wind-down of research and development activities [8] - Applied Therapeutics Inc shares fell 44% to $0.5070 following third-quarter results [8] - EPWK Holdings Ltd shares decreased 33% to $0.0434 after announcing a 40-for-1 share consolidation effective November 17 [8]